Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT)
Glaucoma, Vision Impairment and Blindness, Cataract
About this trial
This is an interventional screening trial for Glaucoma focused on measuring Vision Screening, Follow-up Eye Care, Vulnerable Populations, New York City
Eligibility Criteria
Inclusion Criteria:
- Individuals over age 40
- Living independently in NYCHA housing building or attending DFTA Senior Center
- Willing to answer COVID-19 symptom questions
- Willing to consent for 2 vision screening visits at baseline and 12-month follow-up
Exclusion Criteria:
- Self-reported terminal illness with life expectancy less than 1 year
- Inability to provide informed consent due to dementia or other reasons
Sites / Locations
- Columbia University
Arms of the Study
Arm 1
Arm 2
Active Comparator
Placebo Comparator
Enhanced Intervention
Usual Care
Consented subjects living in buildings randomized to the Enhanced Intervention arm who fail the screening and need vision correction will receive free eyeglasses, which will be fitted by an optician at the housing building. If they are referred to an ophthalmologist for a follow-up eye exam, they will receive enhanced support with patient navigators to assist with all aspects of follow-up eye care and ocular surgery at either Harkness Eye Institute or Harlem Hospital, specifically eye exam appointment scheduling and arranging transportation over a 1-year period.
Consented subjects living in buildings randomized to Usual Care arm who fail the screening and need vision correction will be given an eyeglasses prescription and a list of optical shops within 1 mile from their home. These subjects who are referred to an ophthalmologist for a follow-up eye exam will only be scheduled for their initial appointment at either Harkness Eye Institute or Harlem Hospital. They will not receive enhanced support. Scheduling this initial appointment will allow tracking of adherence.